Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|May 30, 2020
What Do Recent Clinical Trials Teach Us About the Etiology of ADNikolaos K RobakisNeurochemical Research|February 26, 2013
Cell signaling abnormalities may drive neurodegeneration in familial Alzheimer diseaseNikolaos K RobakisNeuro-Degenerative Diseases|February 18, 2010
Are Abeta and its derivatives causative agents or innocent bystanders in AD?Nikolaos K RobakisNeurobiology of Aging|July 3, 2010
Mechanisms of AD neurodegeneration may be independent of Aβ and its derivativesNikolaos K RobakisAmyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 11, 2003
An Alzheimer's disease hypothesis based on transcriptional dysregulationNikolaos K RobakisNeuro-Degenerative Diseases|October 2, 2013
Allelic interference: a mechanism for trans-dominant transmission of loss of function in the neurodegeneration of familial Alzheimer's diseaseNikolaos K Robakis, Anastasios GeorgakopoulosProgress in Neurobiology|May 25, 2012
Cellular mechanisms of γ-secretase substrate selection, processing and toxicityGael Barthet, Anastasios Georgakopoulos, Nikolaos K RobakisNeurobiology of Aging|May 5, 2016
Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutationsAngeliki M Nikolakopoulou, Anastasios Georgakopoulos, Nikolaos K RobakisNeuro-Degenerative Diseases|June 29, 2007
Novel processing of Notch 1 within its intracellular domain by a cysteine proteaseAngeliki Fassa, Loukia Parisiadou, Nikolaos K Robakis, et al.Neuro-Degenerative Diseases|September 7, 2006
It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's diseaseLisette Arnaud, Nikolaos K Robakis, Maria E Figueiredo-PereiraPageof 6